SCP was founded in Medford, Massachusetts, in 2005 to provide consulting services to the biotechnology and clinical diagnostics industry. The strength of SCP is its expertise and experience that bridges technical knowledge with business expertise in the clinical diagnostic industry.

Business and Technical Due Diligence

  • VC and M&A due diligence projects
  • Opportunity analysis from technical capabilities to strategic fit

Technology, Business and Investment Scouting

  • Confidential searches and assessments
  • Efficient through technical expertise and industry relationships
  • Comprehensive financial capability and value analysis
  • Deal closing support

Biomarker Strategy Development

  • Product road-mapping and forecasting
  • In vitro diagnostics (IVD) specialties – nucleic acid testing, proteomics
  • Applications is pathology, oncology, infectious diseases, cardio-vascular disease
  • Strategy critique at mid-development stage
  • Competitive benchmarking
  • Analytical instrument/system design requirements (POC and lab systems)

Custom Competitive Intelligence

  • In depth analysis of competitors’ capabilities
  • Product cost structure and supplier analysis

Interim Executives

  • Providing interim executives in technical, sales & marketing, board and executive functions
  • Product, business and market development support

Clients

  • Early stage companies
  • Pharmaceutical and biotechnology companies
  • Diversified healthcare companies
  • IVD companies of any size
  • Venture funds and investment banks